Similar articles for PMID: 22209866

Year	Number of Results
1975	1
1980	1
1982	1
1990	1
1992	1
1996	3
1997	2
1998	1
1999	3
2000	4
2001	2
2002	4
2003	6
2004	6
2005	3
2006	8
2007	11
2008	7
2009	9
2010	3
2011	10
2012	17
2013	5
2014	3
2015	4
2016	2
2017	3
2018	7
2019	4
2020	1
2021	3
2022	4

1

Pharmacogenomic analysis of ATP-sensitive potassium channels coexpressing the common type 2 diabetes risk variants E23K and S1369A.

Lang VY, Fatehi M, Light PE. Lang VY, et al. Pharmacogenet Genomics. 2012 Mar;22(3):206-14. doi: 10.1097/FPC.0b013e32835001e7. Pharmacogenet Genomics. 2012. PMID: 22209866

2

Coexpression of the type 2 diabetes susceptibility gene variants KCNJ11 E23K and ABCC8 S1369A alter the ATP and sulfonylurea sensitivities of the ATP-sensitive K(+) channel.

Hamming KS, Soliman D, Matemisz LC, Niazi O, Lang Y, Gloyn AL, Light PE. Hamming KS, et al. Diabetes. 2009 Oct;58(10):2419-24. doi: 10.2337/db09-0143. Epub 2009 Jul 8. Diabetes. 2009. PMID: 19587354 Free PMC article.

3

The ATP-sensitive K(+) channel ABCC8 S1369A type 2 diabetes risk variant increases MgATPase activity.

Fatehi M, Raja M, Carter C, Soliman D, Holt A, Light PE. Fatehi M, et al. Diabetes. 2012 Jan;61(1):241-9. doi: 10.2337/db11-0371. Diabetes. 2012. PMID: 22187380 Free PMC article.

4

The effects of mitiglinide (KAD-1229), a new anti-diabetic drug, on ATP-sensitive K+ channels and insulin secretion: comparison with the sulfonylureas and nateglinide.

Sunaga Y, Gonoi T, Shibasaki T, Ichikawa K, Kusama H, Yano H, Seino S. Sunaga Y, et al. Eur J Pharmacol. 2001 Nov 9;431(1):119-25. doi: 10.1016/s0014-2999(01)01412-1. Eur J Pharmacol. 2001. PMID: 11716850

5

Pancreatic beta-cell K(ATP) channel activity and membrane-binding studies with nateglinide: A comparison with sulfonylureas and repaglinide.

Hu S, Wang S, Fanelli B, Bell PA, Dunning BE, Geisse S, Schmitz R, Boettcher BR. Hu S, et al. J Pharmacol Exp Ther. 2000 May;293(2):444-52. J Pharmacol Exp Ther. 2000. PMID: 10773014

6

Haplotype structure and genotype-phenotype correlations of the sulfonylurea receptor and the islet ATP-sensitive potassium channel gene region.

Florez JC, Burtt N, de Bakker PI, Almgren P, Tuomi T, Holmkvist J, Gaudet D, Hudson TJ, Schaffner SF, Daly MJ, Hirschhorn JN, Groop L, Altshuler D. Florez JC, et al. Diabetes. 2004 May;53(5):1360-8. doi: 10.2337/diabetes.53.5.1360. Diabetes. 2004. PMID: 15111507

7

Taurine block of cloned ATP-sensitive K+ channels with different sulfonylurea receptor subunits expressed in Xenopus laevis oocytes.

Lim JG, Lee HY, Yun JE, Kim SP, Park JW, Suh SI, Jang BC, Cho CH, Bae JH, Kim SS, Han J, Park MJ, Song DK. Lim JG, et al. Biochem Pharmacol. 2004 Sep 1;68(5):901-10. doi: 10.1016/j.bcp.2004.05.050. Biochem Pharmacol. 2004. PMID: 15294453

8

ABCC8 polymorphism (Ser1369Ala): influence on severe hypoglycemia due to sulfonylureas.

Sato R, Watanabe H, Genma R, Takeuchi M, Maekawa M, Nakamura H. Sato R, et al. Pharmacogenomics. 2010 Dec;11(12):1743-50. doi: 10.2217/pgs.10.135. Pharmacogenomics. 2010. PMID: 21142918

9

Genetic variations in the pancreatic ATP-sensitive potassium channel, beta-cell dysfunction, and susceptibility to type 2 diabetes.

Chistiakov DA, Potapov VA, Khodirev DC, Shamkhalova MS, Shestakova MV, Nosikov VV. Chistiakov DA, et al. Acta Diabetol. 2009 Mar;46(1):43-9. doi: 10.1007/s00592-008-0056-5. Epub 2008 Aug 29. Acta Diabetol. 2009. PMID: 18758683

10

Variations in tissue selectivity amongst insulin secretagogues: a systematic review.

Abdelmoneim AS, Hasenbank SE, Seubert JM, Brocks DR, Light PE, Simpson SH. Abdelmoneim AS, et al. Diabetes Obes Metab. 2012 Feb;14(2):130-8. doi: 10.1111/j.1463-1326.2011.01496.x. Epub 2011 Nov 3. Diabetes Obes Metab. 2012. PMID: 21923736 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed